What is the appropriate treatment for stress urinary incontinence after transurethral resection of the prostate (TURP)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Treatment of Stress Urinary Incontinence After TURP

For stress urinary incontinence after TURP, begin with conservative management including pelvic floor muscle training for 3-6 months, then proceed to surgical intervention based on incontinence severity: offer artificial urinary sphincter (AUS) for severe incontinence, and consider adjustable balloon devices or male slings for mild-to-moderate incontinence in non-radiated patients. 1

Initial Conservative Management

Start all patients with conservative therapy before considering surgical options:

  • Pelvic floor muscle training (PFMT) should be the first-line approach, though evidence shows limited effectiveness compared to standard care that includes PFMT information 2
  • Conservative therapy typically involves 3-4 sessions over 3 months with a specialist continence physiotherapist or nurse 2
  • Preoperative pelvic floor muscle training has been shown to be protective against postoperative urinary incontinence (OR = 0.604) 3

Important caveat: While PFMT is recommended as initial therapy, the MAPS trial demonstrated that intensive one-to-one physical therapy showed no significant benefit over standard care at 12 months (absolute risk difference of only 3.4% in the TURP group), making it unlikely to be cost-effective 2. However, it remains a low-risk initial approach.

Surgical Management Algorithm

Step 1: Assess Incontinence Severity

Categorize patients as mild, moderate, or severe based on pad count and volume of urine loss:

  • Dry definition: 0-1 security pad or <10 mL urine loss
  • Evaluate with pad count, pad test, and quality-of-life questionnaires

Step 2: Determine Radiation History

Critical decision point: Radiation status fundamentally changes surgical recommendations.

For Non-Radiated Patients:

Severe incontinence:

  • Do NOT offer male slings - they have poor efficacy in severe cases 1
  • Offer AUS as primary option - this is the gold standard with superior outcomes 1

Mild-to-moderate incontinence:

  • Adjustable balloon devices (e.g., ProACT) may be offered with the following counseling 1, 4:

    • Cure rates: 55% (95% CI: 47-63%)
    • Improvement rates: 80% (95% CI: 72-87%)
    • 45% achieve dry status at median 21-month follow-up 4
    • Requires serial outpatient adjustments to optimize efficacy
    • Warning: Higher complication rates than other procedures
      • Intraoperative perforation: 5.3% (range 3.4-8%) 1
      • All-cause explantation rate: 27% (range 7-55%) 1
      • 30-day complication rate: 24% 4
      • Reintervention rate: 24% 4
  • Male slings (e.g., ATOMS device) are alternative options 5:

    • 58% dry rate after standard TURP at median 34 months
    • 90% success rate (overall improvement)
    • Lower removal rate (10%) in non-radiated patients
    • Requires 2-3 adjustments for optimization

For Radiated Patients:

All severity levels:

  • Offer AUS over male slings or adjustable balloons 1
  • Radiation significantly decreases efficacy and accelerates failure rates for all sling types 1
  • AUS revision rates are higher in radiated patients (risk ratio 1.56,16% risk difference), primarily due to erosion 1
  • Exception: Small evidence suggests radiated patients with "normal" cystoscopic appearance may benefit from male slings, but this requires careful patient selection 1

For palliative TURP in radiated patients:

  • ATOMS device shows 50% dry rate and 87% success rate 5
  • Critical warning: 50% removal rate (vs 10% in non-radiated), with infection being the most common complication 5

Key Clinical Pitfalls to Avoid

  1. Do not routinely implant male slings in severe stress incontinence - this is explicitly contraindicated by guidelines 1

  2. Do not underestimate adjustable balloon complications - these devices have the highest intraoperative complication rates among anti-incontinence procedures, requiring provider expertise in device management 1

  3. Do not assume modern radiation techniques eliminate complications - even post-2007 radiation techniques show equivalent complication rates with AUS 1

  4. Do not skip urodynamic evaluation - over 90% of post-TURP stress incontinence cases show sphincter insufficiency on urodynamics 6, which helps confirm diagnosis and rule out other causes

Risk Factors to Consider

Independent risk factors for post-TURP incontinence include:

  • Age ≥65 years (OR = 1.941)
  • Diabetes (OR = 2.488)
  • Surgery duration ≥60 minutes (OR = 1.995) 3

These factors should inform preoperative counseling and may influence timing of intervention.

Related Questions

Three weeks after a GreenLight laser prostatectomy, I have dysuria and hematuria with a negative urine culture; what further evaluation or management is recommended?
I don't want to undergo transurethral resection of the prostate (TURP); will regularly emptying my bladder help?
What intra‑urethral bulking‑agent injection is recommended for a patient with stress urinary incontinence who has failed pelvic‑floor muscle training and wishes to avoid surgery?
What is the recommended treatment for a patient with severe LUTS, mild to moderate prostatomegaly, and a PSA of 0.29?
Is incontinence a long-term side effect after a Transurethral Resection of the Prostate (TURP) procedure?
How should a urinary infection be managed when the urine culture is negative for standard uropathogens and only Mycoplasma hominis is isolated at less than 10,000 colony‑forming units?
Is it safe for a breastfeeding mother to use Difflam lozenges (benzydamine hydrochloride) for a sore throat?
A female patient started on doxycycline for a Mycoplasma hominis urinary infection—how long should the course be continued and when should the therapy be changed?
How is a Baker's cyst diagnosed?
Can a bacterial upper respiratory tract infection cause a white blood cell count of about 23 ×10⁹/L with neutrophilia in a young adult presenting with one week of intermittent fever, productive cough, rhinorrhea, sore throat, headache, and negative influenza and COVID‑19 tests?
Does piperacillin/tazobactam cover gram-negative bacilli?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.